Cognitive Assessment and Potential Treatment of Multiple Sclerosis

A special issue of Brain Sciences (ISSN 2076-3425). This special issue belongs to the section "Neuropsychology".

Deadline for manuscript submissions: closed (15 September 2024) | Viewed by 432

Special Issue Editor

Special Issue Information

Dear Colleagues,

Multiple Sclerosis (MS) is a demyelinating, inflammatory and neurodegenerative disease of the CNS, presenting with multiple non-specific symptoms. Cognitive decline is a symptom commonly seen in MS and is widely recognized as the main cause of job loss and disability. Investigating imaging and serum biomarkers associated with cognitive impairment is a current area of interest. The cognitive reserve that may justify the differences in cognitive loss between individuals with the same disease has been a recent research focus. Although there have yet to be approved treatments, different approaches, such as medications, exercise and cognitive rehabilitation, have been explored. Moreover, disease-modifying therapies have a variable effect on cognition in MS.

In this Special Issue, we welcome manuscripts, including original research and reviews, that address a wide range of topics related to MS-associated cognitive decline. We are particularly interested in articles that provide insight into novel biomarkers of cognitive loss, as well as innovative therapeutic interventions that may stabilize or improve the MS-associated cognitive decline.

Dr. Evanthia Bernitsas
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Brain Sciences is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • multiple sclerosis
  • cognition
  • cognitive reserve
  • memory
  • information processing
  • disease-modifying therapies
  • brain atrophy

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue polices can be found here.

Published Papers

There is no accepted submissions to this special issue at this moment.
Back to TopTop